Prelude Therapeutics stock price
NASDAQ:PRLD · Nasdaq · Healthcare · sector #16Prelude Therapeutics's chart data is dated 2026-10-21. Recorded technical signals: RSI rebound, MACD bullish cross. There are 4 published signal records.
Prelude Therapeutics last closed at $3.65 (+3.40%) on 2026-10-21. Signals today: RSI rebound, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -5.9×. Its overall grade ranks 190 of 727 stocks in Healthcare.
About this company
Prelude Therapeutics last closed at $3.65 (+3.40%) on 2026-10-21. Signals today: RSI rebound, MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 190/727
Valuation grade B+
Related stocks
- Gilead SciencesCompetitor
- NovartisCompetitor
- RocheCompetitor
About Prelude Therapeutics
- What technical signals does Prelude Therapeutics (PRLD) have?
- Prelude Therapeutics current technical signals: RSI rebound, MACD bullish cross.
- Is Prelude Therapeutics a cup-and-handle pattern?
- No. Prelude Therapeutics has no valid Cup signal right now.
- What published figures are available for Prelude Therapeutics?
- Market cap: $182.55M. Trailing 12 months PER: -5.9×. Latest quarter PBR: 2.69×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-22 dataset
Turn what you saw on this name into a strategy
Ask Q about Prelude Therapeutics, or open the plan table on the main site.
Ask Q about Prelude Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.